New Research Published on Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient
News featured in Nutrition Insight
Sabinsa’s Curcumin C3 Reduct ingredient has potential in oral care applications, according to a new clinical trial. The findings build on previous research and show beneficial outcomes for mouth and gum-related diseases.
News featured in Happi.com
Sabinsa has published research building on evidence from a previous trial investigating the potential of Sabinsa’s Curcumin C3 Reduct ingredient in oral care applications.
News featured in Wholefoods Magazine
A new study supports the use of Sabinsa’s Curcumin C3 Reduct as an oral care ingredient, according to a press release.
News featured in Nutraceuticals World
A preliminary study on Canker sores suggests that anti-inflammatory curcumin metabolites reduce inflammation at the source.
